MBE
BMY icon

Michael B. Elefante’s Bristol-Myers Squibb BMY Stock Holding History

Michael B. Elefante’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$536K Sell
9,082
-765
-8% -$43.1K 0.59% 46
2014
Q3 		$504K Sell
9,847
-135
-1% -$6.74K 0.22% 63
2014
Q2 		$484K Sell
9,982
-25
-0.2% -$1.23K 0.2% 64
2014
Q1 		$520K Sell
10,007
-285
-3% -$15.2K 0.22% 59
2013
Q4 		$547K Sell
10,292
-197
-2% -$10K 0.25% 58
2013
Q3 		$486K Buy
10,489
+837
+9% +$36.7K 0.24% 59
2013
Q2 		$432K Buy
+9,652
New +$419K 0.23% 59

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Michael B. Elefante's BMY Position: Q4 2014 in Review

Michael B. Elefante reduced its Bristol-Myers Squibb (BMY) stake by 7.8% in Q4 2014, selling an estimated $43.1K and leaving 9,082 shares worth $536K. The position accounts for 0.59% of the portfolio, ranked #46.

Michael B. Elefante first reported a position in BMY in Q2 2013 and has held it in 7 quarters since. The position peaked at $547K in Q4 2013. 1,411 funds tracked by Wall St. Rank hold BMY as of Q4 2014.

  • Michael B. Elefante held 9,082 shares of Bristol-Myers Squibb worth $536K as of Q4 2014.
  • Michael B. Elefante sold 765 Bristol-Myers Squibb shares in Q4 2014, an estimated $43.1K.
  • Bristol-Myers Squibb made up 0.59% of Michael B. Elefante's portfolio in Q4 2014, its #46 holding.
  • Michael B. Elefante first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 7 quarters since.
  • Michael B. Elefante's Bristol-Myers Squibb position peaked at $547K in Q4 2013.
  • 1,411 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2014.

Based on Michael B. Elefante's 13F filing for Q4 2014, filed 13 Feb 2015.